文献速递心力衰竭与心肌病冠心病

脓毒症诱导的心肌病

Sepsis-induced cardiomyopathy.
PubMed 文献 · Eur Heart J · 2025-01-01

脓毒症是全球危重患者最常见死因,也是冠心病监护病房最常见的非心脏疾病。脓毒症所致心肌功能障碍通常称为脓毒症诱导的心肌病(SICM),以可逆的急性单或双心室收缩和/或舒张功能障碍为特征,与冠状动脉疾病无关。本文综述SICM的流行病学、病理生理和临床表现,为临床管理提供见解。

要点

  • SICM是脓毒症常见并发症,表现为可逆的急性单或双心室收缩和/或舒张功能障碍。
  • SICM与冠状动脉疾病无关,目前缺乏统一定义但被广泛认可。
  • 监测和治疗SICM的目标是恢复组织灌注,深入理解其病程有助于优化干预。

核心结论

  • SICM是脓毒症常见的可逆性心肌功能障碍,深入理解其病程和意义有助于优化干预并改善临床结局。

研究设计与样本

  • 综述,总结SICM的流行病学、病理生理和临床表现。

主要发现

  • 脓毒症是全球危重患者最常见死因,也是冠心病监护病房最常见的非心脏疾病。
  • SICM表现为急性单或双心室收缩和/或舒张功能障碍,与冠状动脉疾病无关,且为可逆性。

临床怎么用

  • 监测和治疗SICM应 directed towards 恢复组织灌注。
  • 更好的理解SICM病程和意义可能有助于优化干预并改善临床结局。

局限性

  • SICM缺乏共识定义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sepsis remains the most common cause of death in critically ill patients worldwide and the most frequent non-cardiac disease diagnosed in the Coronary Care Unit. Myocardial dysfunction caused by sepsis, usually termed 'sepsis-induced cardiomyopathy' (SICM), is common and has long been a subject of interest for intensivists and cardiologists. Despite the lack of a consensus definition, SICM is widely recognized as a reversible condition characterized by acute single or bi-ventricular systolic and/or diastolic dysfunction unrelated to coronary artery disease. While indications for monitoring and treating septic cardiomyopathy are directed towards restoring tissue perfusion, a better understanding of the course and implications of septic cardiomyopathy may help to optimize interventions and improve clinical outcomes. The present review aims to summarize current knowledge on the epidemiology, pathophysiology and clinical presentation of SICM, and to provide insights to aid clinicians in managing affected patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Aissaoui N, Boissier F, Chew M, et al. Sepsis-induced cardiomyopathy. Eur Heart J. 2025. PMID: 40439150. doi:10.1093/eurheartj/ehaf340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。